BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khayznikov M, Hemachrandra K, Pandit R, Kumar A, Wang P, Glueck CJ. Statin Intolerance Because of Myalgia, Myositis, Myopathy, or Myonecrosis Can in Most Cases be Safely Resolved by Vitamin D Supplementation. N Am J Med Sci 2015;7:86-93. [PMID: 25838999 DOI: 10.4103/1947-2714.153919] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 9.9] [Reference Citation Analysis]
Number Citing Articles
1 Hlatky MA, Gonzalez PE, Manson JE, Buring JE, Lee I, Cook NR, Mora S, Bubes V, Stone NJ. Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo. JAMA Cardiol 2022. [DOI: 10.1001/jamacardio.2022.4250] [Reference Citation Analysis]
2 Carallo C, Capozza A, Gnasso A. Effects of Vitamin D Supplementation in Patients with Statin-Associated Muscle Symptoms and Low Vitamin D Levels. Metabolic Syndrome and Related Disorders 2022. [DOI: 10.1089/met.2021.0127] [Reference Citation Analysis]
3 Teo CB, Tan PY, Tay RYK, Khoo J, Watts GF, Loh WJ. Association Between Vitamin D Supplementation and Statin-Associated Muscle Symptoms: A Systematic Review. High Blood Press Cardiovasc Prev 2022;29:337-51. [PMID: 35768686 DOI: 10.1007/s40292-022-00526-5] [Reference Citation Analysis]
4 Penson PE, Bruckert E, Marais D, Reiner Ž, Pirro M, Sahebkar A, Bajraktari G, Mirrakhimov E, Rizzo M, Mikhailidis DP, Sachinidis A, Gaita D, Latkovskis G, Mazidi M, Toth PP, Pella D, Alnouri F, Postadzhiyan A, Yeh H, Mancini GJ, von Haehling S, Banach M, Acosta J, Al‐khnifsawi M, Alnouri F, Amar F, Atanasov AG, Bajraktari G, Banach M, Bhaskar S, Bytyçi I, Bjelakovic B, Bruckert E, Cafferata A, Ceska R, Cicero AF, Collet X, Daccord M, Descamps O, Djuric D, Durst R, Ezhov MV, Fras Z, Gaita D, Hernandez AV, Jones SR, Jozwiak J, Kakauridze N, Kallel A, Katsiki N, Khera A, Kostner K, Kubilius R, Latkovskis G, Mancini GJ, Marais AD, Martin SS, Martinez JA, Mazidi M, Mikhailidis DP, Mirrakhimov E, Miserez AR, Mitchenko O, Mitkovskaya NP, Moriarty PM, Nabavi SM, Nair D, Panagiotakos DB, Paragh G, Pella D, Penson PE, Petrulioniene Z, Pirro M, Postadzhiyan A, Puri R, Reda A, Reiner Ž, Radenkovic D, Rakowski M, Riadh J, Richter D, Rizzo M, Ruscica M, Sahebkar A, Sattar N, Serban M, Shehab AM, Shek AB, Sirtori CR, Stefanutti C, Tomasik T, Toth PP, Viigimaa M, Valdivielso P, Vinereanu D, Vohnout B, von Haehling S, Vrablik M, Wong ND, Yeh H, Zhisheng J, Zirlik A; International Lipid Expert Panel (ILEP). Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP). J cachexia sarcopenia muscle 2022;13:1596-622. [DOI: 10.1002/jcsm.12960] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
5 Hou Q, Pang C, Chen Y. Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis. Am J Cardiovasc Drugs 2022;22:183-93. [PMID: 34296397 DOI: 10.1007/s40256-021-00492-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Gallo A, Perregaux J, Bruckert E. Advances in the management of statin myopathy. Curr Opin Endocrinol Diabetes Obes 2021;28:142-51. [PMID: 33278129 DOI: 10.1097/MED.0000000000000595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Warren T, McAllister R, Morgan A, Rai TS, McGilligan V, Ennis M, Page C, Kelly C, Peace A, Corfe BM, Mc Auley M, Watterson S. The Interdependency and Co-Regulation of the Vitamin D and Cholesterol Metabolism. Cells 2021;10:2007. [PMID: 34440777 DOI: 10.3390/cells10082007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Ganji R, Sa’dinpour A, Seyedian SM, Hesam S, Afshari N, Sahebnasagh A. Comparison of Oral and Injectable Dosage Forms of Vitamin D3 on Resolving Statin-Induced Myopathy: Single Blinded Randomized Controlled Clinical Trial. SN Compr Clin Med 2021;3:1555-1560. [DOI: 10.1007/s42399-021-00906-3] [Reference Citation Analysis]
9 Kassner U, Grunwald S, Spira D, Buchmann N, Bobbert T, Gazzerro E, Hollstein T, Spuler S, Steinhagen-Thiessen E. [Diagnostics and treatment of statin-associated muscle symptoms]. Internist (Berl) 2021;62:827-40. [PMID: 34143250 DOI: 10.1007/s00108-021-01059-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nicholls S, Lincoff AM, Bays HE, Cho L, Grobbee DE, Kastelein JJ, Libby P, Moriarty PM, Plutzky J, Ray KK, Thompson PD, Sasiela W, Mason D, McCluskey J, Davey D, Wolski K, Nissen SE. Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance. Am Heart J 2021;235:104-12. [PMID: 33470195 DOI: 10.1016/j.ahj.2020.10.060] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 36.0] [Reference Citation Analysis]
11 McCullough PJ, McCullough WP, Lehrer D, Travers JB, Repas SJ. Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications. Nutrients 2021;13:1511. [PMID: 33947070 DOI: 10.3390/nu13051511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Hassanin N, Baghdady Y, Shehata M, Wagdi A. The role of vitamin D in statin treated patients complaining of myalagia. Cor Vasa 2021;63:58-65. [DOI: 10.33678/cor.2020.021] [Reference Citation Analysis]
13 Kaur H, Singh J, Kashyap JR, Rohilla R, Singh H, Jaswal S, Kumar R. Relationship Between Statin-associated Muscle Symptoms, Serum Vitamin D and Low-density Lipoprotein Cholesterol - A Cross-sectional Study. Eur Endocrinol 2020;16:137-42. [PMID: 33117445 DOI: 10.17925/EE.2020.16.2.137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Compton ALP, Pepin MJ, Katzenberger DR, Kemp DW, Brown JN. Vitamin D Supplementation During Statin Rechallenge in Patients With a History of Intolerance. Ann Pharmacother 2021;55:814-5. [PMID: 33054316 DOI: 10.1177/1060028020966546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Nikolic D, Banach M, Chianetta R, Luzzu LM, Pantea Stoian A, Diaconu CC, Citarrella R, Montalto G, Rizzo M. An overview of statin-induced myopathy and perspectives for the future. Expert Opin Drug Saf 2020;19:601-15. [PMID: 32233708 DOI: 10.1080/14740338.2020.1747431] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
16 Schweitzer AM, Gingrich MA, Hawke TJ, Rebalka IA. The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations. Eur J Appl Physiol 2020;120:1205-25. [PMID: 32248287 DOI: 10.1007/s00421-020-04360-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wong K, Podboy A, Lavezo J, Goel A. Dead Meat: Glecaprevir/Pibrentasvir-Induced Statin Myonecrosis. Dig Dis Sci 2020;65:399-400. [PMID: 31894484 DOI: 10.1007/s10620-019-05993-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Peng J, Liu Y, Xie J, Yang G, Huang Z. Effects of vitamin D on drugs: Response and disposal. Nutrition 2020;74:110734. [PMID: 32179384 DOI: 10.1016/j.nut.2020.110734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Bartlomiejczyk MA, Penson P, Banach M. Vitamin D and SAMS. Contemporary Cardiology 2020. [DOI: 10.1007/978-3-030-33304-1_14] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Scragg R. The Vitamin D Assessment (ViDA) study - Design and main findings. J Steroid Biochem Mol Biol 2020;198:105562. [PMID: 31809866 DOI: 10.1016/j.jsbmb.2019.105562] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
21 Ward NC, Watts GF, Eckel RH. Statin Toxicity. Circ Res 2019;124:328-50. [PMID: 30653440 DOI: 10.1161/CIRCRESAHA.118.312782] [Cited by in Crossref: 259] [Cited by in F6Publishing: 275] [Article Influence: 86.3] [Reference Citation Analysis]
22 Wenstrup S, Santana A, Jamal A. Does vitamin D supplementation reduce the risk of statin-associated myalgia? EBPR 2019;22:16-17. [DOI: 10.1097/ebp.0000000000000257] [Reference Citation Analysis]
23 Irwin JC, Fenning AS, Vella RK. Geranylgeraniol prevents statin-induced skeletal muscle fatigue without causing adverse effects in cardiac or vascular smooth muscle performance. Transl Res 2020;215:17-30. [PMID: 31491372 DOI: 10.1016/j.trsl.2019.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
24 Scragg RKR. Overview of results from the Vitamin D Assessment (ViDA) study. J Endocrinol Invest 2019;42:1391-9. [DOI: 10.1007/s40618-019-01056-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
25 Pennisi M, Di Bartolo G, Malaguarnera G, Bella R, Lanza G, Malaguarnera M. Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain. Dis Markers 2019;2019:3549402. [PMID: 31019583 DOI: 10.1155/2019/3549402] [Reference Citation Analysis]
26 Pennisi M, Di Bartolo G, Malaguarnera G, Bella R, Lanza G, Malaguarnera M. Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain. Dis Markers 2019;2019:3549402. [PMID: 31019583 DOI: 10.1155/2019/3549402] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
27 Laboy SM, Pulley MT. Statin‐associated muscle symptoms: Does the benefit outweigh the risk factor? Muscle Nerve 2019;59:525-7. [DOI: 10.1002/mus.26470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Taylor BA, Thompson PD. Statin-Associated Muscle Disease: Advances in Diagnosis and Management. Neurotherapeutics 2018;15:1006-17. [PMID: 30251222 DOI: 10.1007/s13311-018-0670-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
29 Papp E, Rylander EE. Does vitamin D supplementation prevent statin-induced myopathy? EBP 2019;22:21-22. [DOI: 10.1097/ebp.0000000000000158] [Reference Citation Analysis]
30 Reddy P, Edwards LR. Magnesium Supplementation in Vitamin D Deficiency. American Journal of Therapeutics 2019;26:e124-32. [DOI: 10.1097/mjt.0000000000000538] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
31 Gröber U, Schmidt J, Kisters K. Important drug-micronutrient interactions: A selection for clinical practice. Crit Rev Food Sci Nutr 2020;60:257-75. [PMID: 30580552 DOI: 10.1080/10408398.2018.1522613] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
32 Rosenson RS. Trial designs for statin muscle intolerance. Curr Opin Lipidol 2017;28:488-94. [PMID: 28832369 DOI: 10.1097/MOL.0000000000000454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Shah P. Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases. Curr Cardiol Rep 2018;20. [DOI: 10.1007/s11886-018-0993-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Trehan N, Afonso L, Levine DL, Levy PD. Vitamin D Deficiency, Supplementation, and Cardiovascular Health. Crit Pathw Cardiol 2017;16:109-18. [PMID: 28742648 DOI: 10.1097/HPC.0000000000000122] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
35 Wu Z, Camargo CA Jr, Khaw KT, Waayer D, Lawes CMM, Toop L, Scragg R. Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study. Atherosclerosis 2018;273:59-66. [PMID: 29684661 DOI: 10.1016/j.atherosclerosis.2018.04.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
36 Laufs U, Filipiak KJ, Gouni-Berthold I, Catapano AL; SAMS expert working group. Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl 2017;26:45-55. [PMID: 28434484 DOI: 10.1016/S1567-5688(17)30024-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
37 Hilton-Jones D. Statin-related myopathies. Pract Neurol 2018;18:97-105. [PMID: 29496886 DOI: 10.1136/practneurol-2017-001738] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
38 Katsiki N, Kolovou G, Perez-Martinez P, Mikhailidis DP. Dyslipidaemia in the elderly: to treat or not to treat? Expert Rev Clin Pharmacol 2018;11:259-78. [PMID: 29303009 DOI: 10.1080/17512433.2018.1425138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Klose G. Sechs Maßnahmen bei Statin-assoziierten Muskelschmerzen. MMW - Fortschritte der Medizin 2018;160:40-43. [DOI: 10.1007/s15006-018-0090-3] [Reference Citation Analysis]
40 Devries S. Coronary Artery Disease. Integrative Medicine 2018. [DOI: 10.1016/b978-0-323-35868-2.00026-8] [Reference Citation Analysis]
41 Patel S, Akhtar N. Fungus Monascus-Fermented Red Yeast Rice (RYR): Natural Therapeutic Statin Source or Mycotoxin? Fungi and their Role in Sustainable Development: Current Perspectives 2018. [DOI: 10.1007/978-981-13-0393-7_38] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Riaz R, Merchant AZ, Ul Haq MS, Nasir SAR, Rizvi Y, Khan JA, Zakaria SM, Jawed H, Hamid K, Zehra NU, Ahmed M, Ali HA, Fatima K. Statins everyday versus alternate days: Is there a difference in myalgia rates? Indian Heart J 2018;70:492-6. [PMID: 30170642 DOI: 10.1016/j.ihj.2017.10.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Jetty V, Glueck CJ, Lee K, Goldenberg N, Prince M, Kumar A, Goldenberg M, Anand I, Wang P. Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy. Vasc Health Risk Manag 2017;13:247-53. [PMID: 28740397 DOI: 10.2147/VHRM.S133690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
44 Sharma N, Cooper R, Kuh D, Shah I. Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort. Sci Rep 2017;7:6578. [PMID: 28747665 DOI: 10.1038/s41598-017-06019-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Ramachandran R, Wierzbicki AS. Statins, Muscle Disease and Mitochondria. J Clin Med 2017;6:E75. [PMID: 28757597 DOI: 10.3390/jcm6080075] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 10.0] [Reference Citation Analysis]
46 Choi J, Khan AM, Jarmin M, Goldenberg N, Glueck CJ, Wang P. Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study. Lipids Health Dis 2017;16:141. [PMID: 28738813 DOI: 10.1186/s12944-017-0493-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
47 Buttar RS, Batra J, Kreimerman J, Aleta M, Melamed ML. Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels. J Gen Intern Med 2017;32:1156-9. [PMID: 28707259 DOI: 10.1007/s11606-017-4115-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
48 du Souich P, Roederer G, Dufour R. Myotoxicity of statins: Mechanism of action. Pharmacology & Therapeutics 2017;175:1-16. [DOI: 10.1016/j.pharmthera.2017.02.029] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 17.4] [Reference Citation Analysis]
49 Merel SE, Paauw DS. Common Drug Side Effects and Drug-Drug Interactions in Elderly Adults in Primary Care. J Am Geriatr Soc 2017;65:1578-85. [PMID: 28326532 DOI: 10.1111/jgs.14870] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
50 Calza L, Magistrelli E, Colangeli V, Borderi M, Contadini I, Bon I, Re MC, Viale P. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients. AIDS 2017;31:681-8. [PMID: 28060020 DOI: 10.1097/QAD.0000000000001397] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
51 Bischoff-Ferrari HA, Fischer K, Orav EJ, Dawson-Hughes B, Meyer U, Chocano-Bedoya PO, Meyer OW, Ernst R, Schietzel S, Eberli F, Staehelin HB, Freystätter G, Roas S, Theiler R, Egli A, Wilson NM. Statin Use and 25-Hydroxyvitamin D Blood Level Response to Vitamin D Treatment of Older Adults. J Am Geriatr Soc 2017;65:1267-73. [PMID: 28240766 DOI: 10.1111/jgs.14784] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
52 Polavarapu A, Hasbani D. Neurological Complications of Nutritional Disease. Seminars in Pediatric Neurology 2017;24:70-80. [DOI: 10.1016/j.spen.2016.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
53 Shah P, Glueck CJ, Goldenberg N, Min S, Mahida C, Schlam I, Rothschild M, Huda A, Wang P. Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study. Lipids Health Dis 2017;16:19. [PMID: 28115017 DOI: 10.1186/s12944-017-0416-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
54 Kolovou V, Bilianou H, Kolovou G. Safe use of statins: focus on muscle toxicity. Clinical Lipidology 2016;11:16-22. [DOI: 10.1080/17584299.2016.1239873] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
55 Taylor BA, Lorson L, White CM, Thompson PD. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain. Atherosclerosis 2017;256:100-4. [PMID: 27993387 DOI: 10.1016/j.atherosclerosis.2016.11.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
56 Pereda CA, Nishishinya MB. Is There Really a Relationship Between Serum Vitamin D (25OHD) Levels and the Musculoskeletal Pain Associated With Statin Intake? A Systematic Review. Reumatología Clínica (English Edition) 2016;12:331-5. [DOI: 10.1016/j.reumae.2016.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
57 Hoel DG, Berwick M, de Gruijl FR, Holick MF. The risks and benefits of sun exposure 2016. Dermatoendocrinol 2016;8:e1248325. [PMID: 27942349 DOI: 10.1080/19381980.2016.1248325] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 10.2] [Reference Citation Analysis]
58 Algharably EA, Filler I, Rosenfeld S, Grabowski K, Kreutz R. Statin intolerance - a question of definition. Expert Opin Drug Saf 2017;16:55-63. [PMID: 27645111 DOI: 10.1080/14740338.2017.1238898] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
59 Sahebkar A, Saboni N, Pirro M, Banach M. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms? J Cachexia Sarcopenia Muscle 2017;8:19-24. [PMID: 27897416 DOI: 10.1002/jcsm.12140] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
60 Geyer C. Lifestyle, Lipids, and Cardiovascular Risk Reduction in a Woman With Metabolically Unhealthy Normal Weight. American Journal of Lifestyle Medicine 2016;10:348-352. [DOI: 10.1177/1559827616654103] [Reference Citation Analysis]
61 Shah P, Glueck CJ, Jetty V, Goldenberg N, Rothschild M, Riaz R, Duhon G, Wang P. Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center. Lipids Health Dis 2016;15:132. [PMID: 27538393 DOI: 10.1186/s12944-016-0302-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
62 Maghsoodi N, Wierzbicki AS. Statin myopathy: over-rated and under-treated? Current Opinion in Cardiology 2016;31:417-25. [DOI: 10.1097/hco.0000000000000282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
63 Coon SA, Ashjian EJ, Herink MC. Current Use of Statins for Primary Prevention of Cardiovascular Disease: Patient-Reported Outcomes and Adherence. Curr Cardiovasc Risk Rep 2016;10. [DOI: 10.1007/s12170-016-0504-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
64 Fernandes V, Santos MJ, Pérez A. Statin-related myotoxicity. Endocrinología y Nutrición (English Edition) 2016;63:239-249. [DOI: 10.1016/j.endoen.2016.05.002] [Reference Citation Analysis]
65 Fernandes V, Santos MJ, Pérez A. Statin-related myotoxicity. Endocrinología y Nutrición 2016;63:239-49. [DOI: 10.1016/j.endonu.2016.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
66 Della Badia LA, Elshourbagy NA, Mousa SA. Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol. Pharmacol Ther 2016;164:183-94. [PMID: 27133571 DOI: 10.1016/j.pharmthera.2016.04.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
67 Jetty V, Glueck CJ, Wang P, Shah P, Prince M, Lee K, Goldenberg M, Kumar A. Safety of 50,000-100,000 Units of Vitamin D3/Week in Vitamin D-Deficient, Hypercholesterolemic Patients with Reversible Statin Intolerance. N Am J Med Sci 2016;8:156-62. [PMID: 27114973 DOI: 10.4103/1947-2714.179133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
68 Pereda CA, Nishishinya MB. Is there really a relationship between serum vitamin D (25OHD) levels and the musculoskeletal pain associated with statin intake? A systematic review. Reumatol Clin 2016;12:331-5. [PMID: 27133556 DOI: 10.1016/j.reuma.2016.03.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
69 Patel S. Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons. World J Microbiol Biotechnol 2016;32:87. [PMID: 27038957 DOI: 10.1007/s11274-016-2035-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 8.7] [Reference Citation Analysis]
70 Glueck CJ, Shah P, Goldenberg N, Prince M, Lee K, Jetty V, Kumar A, Goldenberg M, Wang P. Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥ 70 mg/dl despite maximal tolerated cholesterol lowering therapy. Lipids Health Dis 2016;15:55. [PMID: 26968977 DOI: 10.1186/s12944-016-0227-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
71 Bays H, Kothari SN, Azagury DE, Morton JM, Nguyen NT, Jones PH, Jacobson TA, Cohen DE, Orringer C, Westman EC, Horn DB, Scinta W, Primack C. Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA) 1. Surgery for Obesity and Related Diseases 2016;12:468-95. [DOI: 10.1016/j.soard.2016.01.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
72 Prasad C, Imrhan V, Juma S, Maziarz M, Prasad A, Tiernan C, Vijayagopal P. Bioactive Plant Metabolites in the Management of Non-Communicable Metabolic Diseases: Looking at Opportunities beyond the Horizon. Metabolites 2015;5:733-65. [PMID: 26703752 DOI: 10.3390/metabo5040733] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
73 Backes JM, Ruisinger JF, Barnes BJ, Moriarty PM. Statin Intolerance and Vitamin D Supplementation: Sunny, but a Few Clouds Remain…. N Am J Med Sci 2015;7:337-8. [PMID: 26258084 DOI: 10.4103/1947-2714.161255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
74 Khayznikov M, Kumar A, Wang P, Glueck CJ. Statin Intolerance and Vitamin D Supplementation. N Am J Med Sci 2015;7:339-40. [PMID: 26258085] [Reference Citation Analysis]